The New England Journal of Medicine contains an article on the relative review process and outcomes for the FDA, Health Canada, and the European Medicines Agency, with the surprising finding…
Read More
It is officially the start of summer and our Potpourri is hot, hot, hot, but not steamy! This week we cover why health care IT doesn't seem to create productivity…
Read More
The latest annual report on e-prescribing from SureScripts reveals continued rapid growth. The report also details benefits which appear to flow from greater use of electronic prescribing and opportunities to…
Read More
The Express Scripts 2011 Drug Trend Report shows very low overall growth in drug spending, but continued sharp increases in the specialty sub-category. The firm presents interesting information and evidence…
Read More
Another report that looks at specialty drug spending is issued by the Center for Studying Health System Change. Due to different characteristics of this category, the authors are pessimistic about…
Read More
Among government health care programs, the Part D prescription drug benefit in Medicare has been extremely successful, costing less than projected. Beneficiaries also are satisfied with the program, which consists…
Read More
Our final post on the EMD Serono Specialty Digest, with reference to specialty pharmacy provider trends, oncology and outcomes and comparative effectiveness research.
Read More
A continuation of information from the EMD Serono Specialty Digest, with a focus on trends in spending and utilization management.
Read More
EMD Serono puts out an annual report on specialty drug use that is outstanding. This year's edition carries on the tradition with a plethora of useful data and charts based…
Read More
PMSI has released its 2012 Drug Trend Report for workers' compensation business. Medical costs are an increasing portion of workers' compensation payouts and drug spending, particularly for pain medications, has…
Read More